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Perchlorate (ClO4
–) has been used industri-
ally as an oxidizer for rocket fuels and propel-
lants and in explosives and pyrotechnics. In
the 1950s and 1960s, it was also used as a
treatment for hyperthyroidism associated
with Graves disease. Environmental emissions
have resulted in detection of ClO4
– levels
greater than 4 ppb (micrograms per liter) in
drinking water supplies perhaps affecting over
11 million people in 35 U.S. states (National
Research Council 2005). The detection of
ClO4
– in numerous groundwater sources in
the United States, including those of many
communities in California, has raised con-
cerns about potential health impacts. At ther-
apeutic levels, ClO4
– competitively inhibits
iodide transport, thus reducing the concen-
tration of available iodine for hormone pro-
duction and subsequent release (Wolff 1998).
Specific concerns regarding environmental
exposures pertain to potential disruption of
the thyroid in the newborn and subsequent
neurodevelopmental effects (DiGeorge 1987;
Fisher 1996). Hypothyroidism in newborns
(congenital hypothyroidism) in iodine-suffi-
cient regions is most commonly caused by
developmental defects of the thyroid (thyroid
dysgenesis) (Foley 2000). The prevalence of
thyroid dysgenesis in iodine-sufﬁcient regions
is approximately 1 per 4,000 newborns
(Fisher 1996) and has been reported to
account for up to 80% of cases of congenital
hypothyroidism (Foley 2000).
The hypothalamic–pituitary–thyroid axis
operates as a negative feedback loop to provide
regulation of thyroxine (T4) and thyroid-stimu-
lating hormone (TSH) concentrations and can
be affected by changes in environmental condi-
tions, nutrition, and drugs (Reed 2000;
Scanlon and Toft 2000). Immediately after
birth, a normal surge in TSH concentration
occurs, which falls rapidly after the ﬁrst 24 hr
(de Zegher et al. 1994). Early collection (< 24
hr of age) of screening samples will detect this
physiologic elevation of TSH and may account
for a large portion of false-positive primary con-
genital hypothyroidism (PCH) results (Allen
et al. 1988). Program evaluations of California
newborn screening data showed that ethnicity,
birth weight, and sex inﬂuenced the prevalence
of PCH (Waller et al. 2000). These factors may
apply to concentrations of T4 and TSH as well;
however, very few data have been reported to
evaluate these associations.
Recent epidemiologic studies examined
associations between potential exposure to
ClO4
– from drinking water and newborn
thyroid function or PCH prevalence (Brechner
et al. 2000; Crump et al. 2000; Kelsh et al.
2003; Lamm and Doemland 1999; Li et al.
2000a, 2000b). It has been proposed that con-
sumption of ClO4
– water, at any concentra-
tion, by a mother during pregnancy may
depress thyroid function in her newborn and
therefore increase the risk of PCH or other
neurodevelopmental outcomes.
Published epidemiologic studies have not
shown a consistent association between ClO4
–
in drinking water and congenital hypothy-
roidism or altered thyroid function. One study
of Arizona newborns reported an association
between ClO4
– in drinking water and thyroid
function (Brechner et al. 2000), whereas ﬁve
other studies in California, Nevada, and Chile
did not provide evidence supporting this asso-
ciation (Crump et al. 2000; Kelsh et al. 2003;
Lamm and Doemland 1999; Li et al. 2000a,
2000b). Interestingly, no association was noted
between exposure to ClO4
– in drinking water
and TSH in two studies with more quantita-
tive exposure information (Crump et al. 2000;
Li et al. 2000a). Thus, it is possible that the
inconsistent results regarding exposure to
ClO4
– in drinking water and TSH concentra-
tions in newborns may be the result of
methodologic issues (Kelsh et al. 2003; Lamm
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Perchlorate (ClO4
–) has been detected in groundwater sources in numerous communities in
California and other parts of the United States, raising concerns about potential impacts on
health. For California communities where ClO4
– was tested in 1997 and 1998, we evaluated the
prevalence of primary congenital hypothyroidism (PCH) and high thyroid-stimulating hormone
(TSH) levels among the 342,257 California newborns screened in 1998. We compared thyroid
function results among newborns from 24 communities with average ClO4
– concentrations in
drinking water > 5 µg/L (n = 50,326) to newborns from 287 communities with average concentra-
tions ≤ 5 µg/L (n = 291,931). ClO4
– concentrations obtained from the California Drinking Water
Program provided source-speciﬁc data for estimating weighted average concentrations in commu-
nity water. Fifteen cases of PCH from communities with average concentration > 5 µg/L were
observed, with 20.4 expected [adjusted prevalence odds ratio (POR) = 0.71; 95% conﬁdence inter-
val (CI), 0.40–1.19]. Although only 36% of all California newborns were screened before 24 hr of
age in 1998, nearly 80% of newborns with high TSH were screened before 24 hr of age. Because
of the physiologic postnatal surge of TSH, the results for newborns screened before 24 hr were
uninformative for assessing an environmental impact. For newborns screened ≥ 24 hr, the
adjusted POR for high TSH was 0.73 (95% CI, 0.40–1.23). All adjusted odds ratios (ORs) were
controlled for sex, ethnicity, birth weight, and multiple birth status. Using an assessment of ClO4
–
in drinking water based on available data, we did not observe an association between estimated
average ClO4
– concentrations > 5 µg/L in drinking water supplies and the prevalence of clinically
diagnosed PCH or high TSH concentrations. Key words: drinking water, newborn screening, per-
chlorate, primary congenital hypothyroidism, thyroid-stimulating hormone. Environ Health
Perspect 114:798–804 (2006). doi:10.1289/ehp.8176 available via http://dx.doi.org/ [Online
15 December 2005]2003). The objectives of this investigation were
to assess whether there was epidemiologic
evidence of higher rates of PCH or high TSH
levels among newborns in California commu-
nities with and without detectable ClO4
– in
their drinking water supplies, and to evaluate
the extent to which inconsistent results could
be the result of the methodologic differences
noted (Kelsh et al. 2003; Lamm 2003). This
study expanded our earlier investigation of
PCH and TSH concentrations in a southern
California community where ClO4
– had been
detected (Kelsh et al. 2003). The present study
used data from the California Newborn
Screening (NBS) Program for 1998 to examine
the prevalence of PCH and TSH levels for all
California newborns whose mothers resided in
communities where water supplies were tested
for ClO4
– in 1997 and 1998.
Until late 1997, California used a two-
tiered T4-TSH screening program to screen for
PCH. In this program, all newborns were
screened for T4, and only those with a low T4
(e.g., < 10 µg/dL) had their TSH measured.
Beginning in December 1997, the California
Department of Health Services (DHS) NBS
Program replaced the two-stage screening pro-
cedures with TSH-only testing for PCH. Thus,
since late 1997, TSH has been measured for all
California newborns tested under the new pro-
gram. TSH concentration is considered a more
stable biomarker for the evaluation of potential
PCH than T4 (DiGeorge 1987; Fisher 1996).
According to the American Academy of
Pediatrics (1993), the ideal time to collect
blood from newborns for TSH screening is
between 2 and 6 days of age.
This research was reviewed and approved
by the Committee for the Protection of
Human Subjects of DHS for the use of NBS
Program data. A subset of the genetic screen-
ing data relevant to hypothyroidism and TSH
(excluding personal identifying information)
was made available to the research team by
the Genetics Disease Branch (GDB) of DHS,
and the data analyses were conducted in col-
laboration with investigators of the GDB of
DHS (FWL and LP).
Materials and Methods
Study population. The study population
consisted of all California newborns screened
by the California NBS Program in 1998 whose
mothers resided in communities where
groundwater drinking sources were tested for
ClO4
– by the California Drinking Water
Program (DWP). Newborns in this study were
classiﬁed into ClO4
– exposure groups based on
the average ClO4
– concentrations calculated
for the mother’s city of residence. The ClO4
–
water-testing data that corresponded to the
available NBS Program data (birthdates
January 1998–December 1998) were the 1997
and 1998 DWP testing data. There were
nearly 800 water sources from approximately
150 different water systems tested for ClO4
– in
the 1997–1998 period, representing approxi-
mately 200 California communities. Cities and
towns served by water systems that were not
tested for ClO4
– in 1997 or 1998 were not
included in this analysis. This resulted in the
exclusion of 166,894 of 509,151 (32.8%)
1998 newborns for whom exposure data were
unavailable. To address the potential impact of
the Colorado River as a source of ClO4
–, we
conducted a subgroup analysis that included
the 102,966 newborns from communities that
did not receive Colorado River water and
where groundwater was tested for ClO4
– and
the 239,291 newborns who lived in areas that
received Colorado River water. Colorado River
water has had ClO4
– contamination at various
concentrations depending on where measure-
ments were taken. The concentration at the
point where water was diverted for use in
southern California ranged from 5.0 to 9.0
µg/L (U.S. EPA 1999). Colorado River water
was then mixed with other sources before
delivery to consumers. The proportion of
Colorado River water in southern California
drinking water varied considerably depending
upon the city and time of year.
Study variables. Information abstracted
from the NBS Program records for 1998 was
used to construct variables for this analysis.
Some missing or erroneous values were
imputed or corrected. Details of the data edit-
ing and management process have been
described elsewhere (Kelsh et al. 2003). The
health or biomarkers outcomes investigated
were diagnosis of PCH and high TSH level
(defined by GDB as > 25 µU/mL). Elevated
TSH is a biomarker for thyroid function,
whereas PCH is a speciﬁc clinical end point.
The newborn’s physician is responsible for
reporting conﬁrmed diagnosis of PCH to the
screening program. Once physicians are alerted
to a newborn with high TSH concentration,
diagnosis of PCH is generally based on conﬁr-
matory tests of serum free T4 and TSH levels
and a detailed physical examination and
neonatal history. Assessment may also include
thyroid scanning and testing of serum-binding
proteins and serum triiodothyronine levels.
Covariate data available from the new-
born screening records included age (in hours
of life) at time of specimen collection, sex,
race/ethnicity, birth weight, and multiple
birth status. The exposure variable derived
from the California DWP was average ClO4
–
concentration categorized as > 5 µg/L and ≤ 5
µg/L. In addition, a Colorado River indicator
variable was assigned to each record if the
mother’s residence received drinking water
from the Colorado River.
California DWP. The DWP of the
California DHS was established to monitor
water sources of public water systems.
Approximately 80 chemical and six radiological
contaminants for which maximum contami-
nant levels (MCLs) have been established are
monitored (California DHS 2003a). The
DWP also monitors concentrations of other
chemicals for which no MCL has been estab-
lished. In 1997 and 1998, ClO4
– was one of
the unregulated chemicals monitored by DHS.
The DWP initiated ClO4
– testing of drinking
water wells in February 1997 (California DHS
2003b). These data are organized by water sys-
tem (water company, distributor, or private
entity such as a mobile home park); data for
each water system may include testing data
from multiple sources or wells, and each source
may have been tested on multiple occasions.
ClO4
– exposure estimates were based on
samples from wells tested for ClO4
– from
February 1997 through December 1998. We
selected 1997 and 1998 water data, assuming
these years would span the gestation periods
for the 1998 newborns. Because testing data
after 1998 may not accurately characterize
concentrations in water sources in the 1997
and 1998 period, post-1998 ClO4
– testing
data were not used. Analysis of post-1998
water quality data showed that about 90% of
the groundwater sources tested in 1997–1998
were tested again sometime after 1998 and
before March 2003. The median number
of additional tests performed after 1998 was
four (range 1–202). The concentrations in
1997–1998 and subsequent tests were below
the nominal detection limit of 5 µg/L for 79%
of the water sources with post-1998 testing.
Of the remaining sources tested, 15% showed
no statistically signiﬁcant difference in ClO4
–
concentration from samples tested in the two
time periods, 3.4% showed a significant
increase, and 2.6% had a signiﬁcant decrease
in ClO4
– concentration. Thus, most ground-
water sources remained at below-detection
concentration level or showed no significant
change in concentration after 1998.
DWP measurements for ClO4
– concentra-
tions below the test detection limits were
recorded inconsistently. Sample concentrations
where ClO4
– was not detected were recorded
either as 0.0, < 4, or < 5 µg/L. Most measure-
ments that yielded concentrations too low to
quantify were recorded as < 4 or < 5 µg/L
based on the lower detection limit at the time
of 4–5 µg/L. From 1997 and 1998, 48 water
systems had one or more samples with
detectable ClO4
–, and 151 water systems had
no detectable ClO4
– in any of their samples.
We selected the cutoff point of 5 µg/L to
represent concentrations at or below 5 µg/L.
Information for cities or towns served by
each water system tested by the DWP was
collected either from the DWP file or
through Internet searches or telephone inter-
views conducted by research staff. In addition
to relying on local groundwater wells, water
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distributors and wholesalers. Many southern
California communities also receive a portion
of their water from the Metropolitan Water
District (MWD) of Southern California. The
MWD distributes northern California and
Colorado River surface water to 26 water sys-
tems that provide drinking water to nearly 18
million southern California residents (MWD
2003a). Information on Colorado River water
allocations was collected through Internet
searches and telephone inquiries to major
southern California water wholesalers and the
Colorado River Water Users Association
(Colorado River Water Users Association
2003; MWD 2003b). This information was
used to determine whether each city received
Colorado River water.
Six samples from four MWD sources
were tested in 1997 and 1998. The highest
ClO4
– concentration for these years was 9.0
µg/L, with an average of 4.1 µg/L. No public
data source was available to identify the
amount of water provided by the MWD to its
afﬁliated water systems. Thus, after blending
and mixing with other sources, the propor-
tion of MWD-supplied water reaching con-
sumers in a particular community at a
particular time could not be determined.
In the absence of detailed and complete
information on water distribution practices
for each California water system, the follow-
ing methods were adopted to estimate average
ClO4
– concentrations for each water system
and city. The average water system ClO4
–
concentration was the arithmetic mean of
median concentrations from each contribut-
ing water source or well. The average ClO4
–
concentration for a given city was then calcu-
lated as the weighted average of concentra-
tions from the different water systems that
provided drinking water to the city, weighted
by the number of water sources, counting the
MWD as one source. Thus, the ClO4
– con-
centration for a community was estimated as
[1]
where ni is the number of drinking water
sources contributed by the ith water system,
Ci is the ClO4
– average concentration for the
ith water system, and N is the total number of
sources from all contributing water systems.
Statistical analysis. Primary congenital
hypothyroidism. We examined the relation-
ship between PCH occurrence and potential
ClO4
– exposure using logistic regression mod-
els to estimate adjusted prevalence odds ratios
(PORs). In addition to the drinking water
ClO4
– classiﬁcation of ≤ 5 µg/L or > 5 µg/L,
covariates in the logistic regression analyses for
PCH included birth weight, ethnicity, sex, and
indication of multiple births. Only the first
newborn in a multiple birth was retained for
analysis, as characteristics of the subsequent
newborns were unlikely to be independent.
Thyroid-stimulating hormone. The
potential relationship between high TSH
level and residence in communities with
detectable ClO4
– in drinking water was
examined using logistic regression models to
estimate adjusted PORs. The continuous
TSH variable was dichotomized into “high”
or “normal” based on the 1998 DHS GDB
cutoff value of 25 µU/mL.
Covariates were those used in the PCH
analyses as well as age at time of blood sample
collection. Given the documented physiologic
postnatal surge of TSH before 24 hr of age, we
restricted the TSH analyses to those newborns
with an age at specimen collection ≥ 24 hr. In
our analyses, we also examined the subgroup of
newborns with normal birth weights. Two-way
interactions were examined and found to have
minimal effect on the POR and thus were not
included in the ﬁnal model.
Results
Newborn screening data. Of the initial
515,476 records for California newborns
whose screening data had accession dates
(date the specimen arrived at the laboratory)
from January to December 1998, 6,325
(1.23%) could not be included because of
incomplete or inadequate data. The remain-
ing birth records totaling 509,151 in the ﬁnal
data file included 201 diagnosed with PCH
and 989 infants with TSH level > 25 µU/mL.
Of the 509,151 California newborns with
complete data, 342,257 newborns were iden-
tified as residing in communities where
groundwater wells were tested for ClO4
–. Of
these records, 50,326 newborns from 24
communities resided in areas with average
ClO4
– concentrations in drinking water
sources > 5 µg/L, and 291,931 newborns
from 287 communities resided in areas with
average ClO4
– concentrations ≤ 5 µg/L. No
apparent biases were evident as a result of the
3,584 records deleted because of various miss-
ing demographic data or screening test char-
acteristics. Overall, 0.95% of records were
deleted from the communities with average
ClO4
– concentrations > 5 µg/L compared
with 1.05% deleted from communities with
average ClO4
– concentrations ≤ 5 µg/L in
drinking water (Appendix 1). In addition, a
sensitivity analysis, in which newborns from
cities and towns where groundwater was not
tested were classiﬁed into the low concentra-
tion category, did not signiﬁcantly change the
study ﬁndings.
DWP water survey. Overall, communities
from 20 California counties were tested
for ClO4
– (Appendix 2). Four southern
California counties (Los Angeles, Orange,
Riverside, and San Bernardino) and one
northern California county (Sacramento) had
a total of 24 communities with average ClO4
–
concentrations in drinking water > 5 µg/L,
based on the California DWP data for
1997–1998. In the same five counties, there
were 199 communities with average ClO4
–
concentrations ≤ 5 µg/L.
Primary congenital hypothyroidism. Of
the 201 newborns diagnosed with PCH in
California in 1998, 141 newborns were from
communities receiving drinking water that
had been tested for ClO4
– (Table 1). Fifteen
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Table 2. ORs and 95% CIs for PCH by ClO4
– exposure classiﬁcation, Colorado River water status, and birth
weight, California newborns,a 1998.
Average ClO4
– concentrations
≤ 5 µg/L > 5 µg/L
No PCH PCH No PCH PCH PORb (95% CI)
All California communities
All birth weights 287,754 122 49,622 15 0.71 (0.40–1.19)
Normal birth weightc 241,275 100 41,615 11 0.64 (0.32–1.15)
California communities not receiving Colorado River water
All birth weights 76,972 30 24,378 10 1.14 (0.52–2.28)
Normal birth weight 64,323 24 20,235 7 1.01 (0.39–2.26)
Colorado River water communities (California)
All birth weights 210,782 92 25,244 5 0.43 (0.15–0.96)
Normal birth weight 176,952 76 21,380 4 0.49 (0.13–0.98)
aOnly ﬁrst born of multiple births were included in these analyses. bPOR was adjusted for race, sex, birth weight, multiple
birth, and Colorado River water use. cNewborns with normal birth weight (2,500–4,000 g).
Table 1. Number of newborns tested, number with high TSH, and number of PCH cases by ClO4
– exposure
classiﬁcation,a California, 1998.
Population after data editingb
Exposure classiﬁcation Total High TSH (%) PCH (%)
All newborns from California communities tested for ClO4
– 342,257 684 (0.20) 141 (0.04)
Newborns from communities with average ClO4
– concentrations > 5 µg/L 50,326 147 (0.29) 15 (0.03)
Newborns from communities with average ClO4
– concentrations ≤ 5 µg/L 291,931 537 (0.18) 126 (0.04)
aTesting results provided by California DHS DWP. bSome records may have invalid or missing information for more than
one variable. cases (10.6%) were from areas with average
ClO4
– concentrations in drinking water > 5
µg/L (20.4 cases were expected), and 126
(89.4%) cases of PCH were from communi-
ties with average concentrations of ClO4
– in
drinking water ≤ 5 µg/L (Table 1). After con-
trolling for sex, ethnicity, multiple birth sta-
tus, and birth weight, the POR for PCH was
not increased for 1998 California newborns
whose mothers resided in communities with
average ClO4
– concentrations > 5 µg/L (POR
= 0.71; 95% CI, 0.40–1.19) (Table 2). For
newborns in the normal birth weight category
(2,500–4,000 g), the POR was slightly lower
for newborns from communities with average
ClO4
– concentration > 5 µg/L (POR = 0.64;
95% CI, 0.32–1.15) than the results for all
birth weights (Table 2).
Among newborns from areas that did not
receive Colorado River water but had average
ClO4
– concentrations > 5 µg/L, the POR for
PCH was near 1 (POR = 1.14; 95% CI,
0.52–2.28). In this analysis of communities
that did not receive Colorado River water, the
OR for newborns in the normal birth weight
category (POR = 1.01; 95% CI, 0.39–2.26)
was slightly lower than the OR for all new-
borns. The POR among communities that
received Colorado River water was not ele-
vated (POR = 0.43; 95% CI, 0.15–0.96).
Similar to previous reports of California
newborn data (Lorey and Cunningham 1992;
Waller et al. 2000), female newborns had a
higher risk for PCH (POR = 1.94; 95% CI,
1.37–2.78). Variation by race/ethnicity status
was also observed with Asians (POR = 1.83;
95% CI, 0.94–3.50) and Hispanics (POR =
2.17; 95% CI, 1.36–3.63) having higher
risks, and African Americans (POR = 0.29;
95% CI, 0.05–0.99) having lower risks com-
pared with whites. Low birth weight status (<
2,500 grams) was also associated with PCH
(POR = 1.90; 95% CI, 0.99–3.31).
TSH. There were 684 newborns identi-
fied as having high TSH levels among
342,257 newborns screened from communi-
ties where drinking water was tested for
ClO4
– (Table 1). Of these, 537 (78.5%) were
from communities with average ClO4
– con-
centrations in drinking water ≤ 5 µg/L, and
147 (21.5%) were from areas with average
ClO4
– concentrations > 5 µg/L.
TSH concentrations rose rapidly as
expected in the ﬁrst 12 hr of life, then declined,
stabilized by 24 hr after birth, and continued to
decline (Figure 1). Among newborns from
communities with drinking water tested for
ClO4
–, 123,583 (36.1%) had their blood sam-
ple collected for TSH screening at < 24 hr of
age. The majority of newborns (79.7%) with
high TSH in both exposure groups were
screened at < 24 hr of age (Table 3). Of the
102,966 newborns from communities that did
not receive Colorado River water and had water
system groundwater wells tested for ClO4
–, 230
newborns were identiﬁed as having high TSH,
and 188 (81.7%) of these newborns had blood
specimens collected < 24 hr (Table 3).
The adjusted POR associated with high
TSH among newborns screened ≥ 24 hr of age
and whose mothers resided in communities
with average ClO4
– concentrations > 5 µg/L
was 0.73 (95% CI, 0.40–1.23) (Table 4). For
newborns of normal birth weight, screened
≥ 24 hr of age, the OR for high TSH was also
not elevated (POR = 0.74; 95% CI, 0.37–1.33).
For communities that did not receive
Colorado River water, the POR for high TSH
followed a similar pattern. The adjusted POR
for high TSH in communities with average
ClO4
– concentrations > 5 µg/L was 0.87
(95% CI, 0.37–1.83). Among normal birth
weight newborns, the POR for high TSH was
also not increased (POR = 0.71; 95% CI,
0.24–1.77) (Table 4). Among southern
California residents who received Colorado
River water, the POR was not elevated (POR
= 0.57; 95% CI, 0.22–1.20) (Table 4).
Of the demographic factors and birth char-
acteristics examined in our multivariate models,
females had a higher risk for high TSH (POR =
1.89; 95% CI, 1.33–2.71) compared with
males. By race/ethnicity status, results for high
TSH were similar to the findings for PCH,
with modest elevations for Asians (POR = 1.37;
95% CI, 0.73–2.48) and Hispanics (POR =
1.40; 95% CI, 0.91–2.20) and a decrease for
African Americans (POR = 0.40; 95% CI,
0.12–1.02) compared with whites. Birth weight
and multiple birth status were not associated
with high TSH (data not shown).
Discussion
This statewide study was initiated as a follow-
up analysis to a previous study of a southern
California community (Kelsh et al. 2003) to
verify whether similar findings would be
observed in a larger study population. In addi-
tion to the increased sample size, this study of
1998 California NBS Program data offered
several other analytical advantages. First, 1998
was the first year that TSH testing was con-
ducted for all California newborns. Second,
ClO4
– drinking water monitoring data for the
period 1997–1998 were available for a large
number of drinking water sources in California
to link with the NBS Program data. We
observed 15 cases of PCH in 1998 in areas of
California where ClO4
– was detected at average
concentrations > 5 µg/L, while 20.4 cases were
expected. When we compared PCH cases in
communities with average ClO4
– concentra-
tion > 5 µg/L that did not receive Colorado
River water, we did not ﬁnd an excess number
of cases, nor was an excess number of cases
observed among the population receiving
Colorado River water as a drinking source.
In addition, we did not find evidence of
high TSH levels for California newborns
whose mothers resided in communities with
average ClO4
– drinking water concentrations
> 5 µg/L. When we compared California
communities that did not receive Colorado
River water but had average ClO4
– concentra-
tions > 5 µg/L, there was also no excess risk of
high TSH levels.
Perchlorate and California newborns
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Figure 1. TSH concentrations at 25th, median, and 90th percentiles by specimen collection time, California
newborns, 1998. Included only newborns from areas where water system groundwater was tested for
ClO4
– in 1997–1998.
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P90%Although slightly more than one third of
all newborns in the study population were
screened within the first 24 hr of life, the
majority of newborns (79.7%) with high
TSH concentrations were screened within the
ﬁrst day. The strong effect of time of sample
collection on TSH level dictated our focus on
TSH results after 24 hr of age. Given the
large number of newborns with high TSH
screened within the first 24 hr of life, this
approach was considered more appropriate
than analyses including all newborns regard-
less of sampling age and attempting to control
for this powerful confounding factor in the
data analysis.
Limitations. The California DHS uses
nine screening laboratories that serve various
geographic regions of the state. Thus, it is pos-
sible that laboratory variation may affect the
outcome of TSH screening as a result of slight
variations in methods and procedures and
changes in personnel. This possibility was
evaluated and appears unlikely, because the
GDB uses standardized protocols and rigorous
quality control procedures for all laboratory
procedures. In addition, laboratory variation
would more likely occur across years rather
than within 1 year, as we have analyzed here.
Because we were using data for drinking
water at a community level, the exposure clas-
sification protocol that we adopted does not
account for variation due to individual con-
sumption patterns (e.g., bottled water) or
migration into and out of communities result-
ing from residential mobility or travel to work
sites outside of mothers’ residential communi-
ties. In addition, the very dynamic and com-
plex water systems for many of the study
communities rely on several water sources,
which often contribute different proportions
of water at different times of the year. Speciﬁc
water allocation data were not available for
many of the different water companies.
Our method of averaging ClO4
– concentra-
tions based on water testing assumed that each
water source contributed an equal proportion
of water to the communities it served. Because
of the uncertainty of this assumption, we used
this calculation only to group communities into
categories of potentially exposed (estimated
average ClO4
– concentration > 5 µg/L) and
likely not exposed (estimated average ClO4
–
concentration ≤ 5 µg/L). This method does not
incorporate personal water consumption pat-
terns or the mixing of multiple water sources by
water companies. Given the limitation of this
method, these calculations were not used to
conduct potential dose–response analyses.
Comparison with previous epidemiologic
studies of newborns. Previous published stud-
ies have evaluated potential associations
between T4, TSH, or PCH and ClO4
– expo-
sure in newborn populations in California,
Nevada, Arizona, and Chile (Brechner et al.
2000; Crump et al. 2000; Kelsh et al. 2003;
Lamm and Doemland 1999; Li et al. 2000a,
2000b). We focused our analysis on PCH as a
signiﬁcant disease and on TSH as a sensitive
indicator of thyroid function. TSH is consid-
ered a more sensitive and speciﬁc indicator for
assessing subclinical thyroid function than T4
(Nordyke et al. 1998) and is the preferred
screening test for PCH (American Academy
of Pediatrics 1993).
The results of the current study were simi-
lar to those of previous studies with respect to
risk factors for PCH and elevated TSH levels
(Kelsh et al. 2003; Lorey and Cunningham
1992; Waller et al. 2000). We found that eth-
nicity, sex, and birth weight were consistent
predictors of PCH, whereas specimen collec-
tion time had the most pronounced effect on
TSH levels (Allen et al. 1990; Waller et al.
2000). Blood samples collected at < 24 hr of
age had much higher TSH levels than those
collected 1 day or more after birth. When age
at specimen collection time was taken into
account, no differences in TSH level were
observed between newborns from communi-
ties with average ClO4
– concentrations in
drinking water ≤ 5 µg/L and > 5 µg/L.
In this analysis of California newborns, we
studied a much larger number of newborns
with TSH results compared with previous
studies in Chile, Arizona, and Nevada
(Brechner et al. 2000; Crump et al. 2000; Li
et al. 2000a). However, in each of those
smaller studies, exposure information was
likely more precise because the communities
studied relied solely on one water supply,
whereas across California, communities often
rely on multiple water sources.
Our findings are consistent with previ-
ously published analyses of exposure to ClO4
–
in drinking water and PCH and TSH, with
the exception of the analysis of Arizona new-
borns by Brechner et al. (2000). No increase
in the number of PCH cases was found in
counties where ClO4
– had been detected in
California and Nevada well water supplies
(Lamm and Doemland 1999). Likewise, there
was no association between TSH concentra-
tion and low-level ClO4
– exposures in drink-
ing water among newborns in a study of Las
Vegas and Reno, Nevada (Li et al. 2000a). In
a Chilean study of three regions with high,
medium, and nondetectable ClO4
– concen-
trations in drinking water (Crump et al.
2000), no associations between newborns’
TSH concentrations and ClO4
– region or
between childhood TSH concentrations and
lifetime residence in the three regions were
reported. Our results were also similar to the
ﬁndings of a 15-year study of newborns in a
Buffler et al.
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Table 3. Distribution of high TSH [no. (%)] by ClO4
– exposure classiﬁcation, Colorado River water status,
and specimen collection time, California newborns, 1998.
High TSH [n (%)]
Average ClO4
– concentrations All communities
≤ 5 µg/L > 5 µg/L tested for ClO4
–
California communities
Specimen collection < 24 hr 413 (76.9) 132 (89.8) 545 (79.7)
Specimen collection ≥ 24 hr 124 (23.1) 15 (10.2) 139 (20.3)
Total 537 (100) 147 (100) 684 (100)
California communities not receiving Colorado River water
Specimen collection < 24 hr 124 (79.0) 64 (87.7) 188 (81.7)
Specimen collection ≥ 24 hr 33 (21.0) 9 (12.3) 42 (18.3)
Total 157 (100) 73 (100) 230 (100)
Colorado River water communities (California)
Specimen collection < 24 hr 289 (76.1) 68 (91.9) 357 (78.6)
Specimen collection ≥ 24 hr 91 (23.9) 6 (8.1) 97 (21.4)
Total 380 (100) 74 (100) 545 (100)
Table 4. ORs and 95% CIs for high TSH by ClO4
– exposure classiﬁcation, Colorado River water status, and
birth weight, California newborns,a 1998.
Average ClO4
– concentrations
≤ 5 µg/L > 5 µg/L
Normal High Normal High
TSH TSH TSH TSH PORb (95% CI)
All California communities
All birth weights 185,409 119 29,100 14 0.73 (0.40–1.23)
Normal birth weightc 152,266 94 23,679 11 0.74 (0.37–1.33)
California communities not receiving Colorado River water
All birth weights 46,653 32 13,113 8 0.87 (0.37–1.83)
Normal birth weight 38,121 24 10,462 5 0.71 (0.24–1.77)
Colorado River water communities (California)
All birth weights 138,756 87 15,987 6 0.57 (0.22–1.20)
Normal birth weight 114,145 70 13,217 6 0.70 (0.27–1.49)
aMultiple births represented once; specimen collection ≥ 24 hr for all newborns was analyzed and adjusted for ethnicity,
sex, multiple birth status, and birth weight. bPOR was adjusted for race, sex, birth weight, multiple birth, and Colorado
River water use. cNewborns with normal birth weight (2,500–4,000 g).southern California community (Kelsh et al.
2003). However, our results differed from
those reported among Arizona newborns
(Brechner et al. 2000). Further investigation
of this study population suggests that differ-
ences in medical procedures, hospital prac-
tices, or other regional or demographic factors
provide a more likely explanation of the TSH
concentration differences observed for new-
borns in Yuma and Flagstaff than drinking
water exposure to ClO4
– (Goodman 2001;
Lamm 2003).
Despite use of the same California new-
born screening data (although for different
years), our results do not support the ﬁndings
of an unpublished analysis of ClO4
– and TSH
of California newborns in 1996, when the
two-stage screening for PCH was in place
(Schwartz 2001). As previously described,
methodological and analytic differences
between the study presented here and that of
Schwartz do not allow for direct comparison of
ﬁndings (Kelsh et al. 2003). These differences
include evaluation of TSH data as a continu-
ous variable in the Schwartz analyses and a
dichotomous variable in this study. Analysis of
TSH as a continuous variable would have to
address the issue that more than 50% of the
newborns screened had a value of 5 µU/mL
recorded, because any TSH concentration
below the limit of detection was recorded or
censored at 5 µU/mL. Although this trunca-
tion of the data would not pose a problem for a
screening program, ignoring the censoring of
the data would distort the results when they are
analyzed as a continuous variable in analysis of
variance models. In addition, results reported
by Schwartz suggest that several variables, espe-
cially the newborn blood specimen collection
hour, appear to have been processed incorrectly
in the Schwartz analyses, leading to misclassiﬁ-
cation of a signiﬁcant number of newborn data
records. The exposure assignment procedures
used by Schwartz were also different but were
not adequately documented to permit a com-
parison with our protocol. Thus, the different
time periods examined, the different statistical
analyses applied, the different exposure assign-
ment procedures implemented, and the data
misclassiﬁcation errors that we identiﬁed in the
Schwartz analyses have led to different results
and conclusions between the current investiga-
tion and the Schwartz unpublished analysis.
Other studies. In addition to the commu-
nity studies of newborn thyroid function and
ClO4
– concentrations in drinking water, sev-
eral adult studies of thyroid disease and can-
cer have not identified an association with
ClO4
– in drinking water or occupational
ClO4
– exposure (Gibbs et al. 1998; Lamm
et al. 1999; Li et al. 2001; Morgan and
Cassady 2002).
In an early study of treatment for hyper-
thyroidism, 11 of 12 newborns of mothers
taking potassium ClO4
– at 600 mg or 1,000
mg daily exhibited no abnormalities, while
one had a transiently enlarged thyroid
(Crooks and Wayne 1960). A recent volun-
teer study suggested that ClO4
– in drinking
water at the equivalent of 180–220 µg/L daily
results in no effect on thyroid function (Greer
et al. 2002). Given that the ClO4
– concentra-
tions in California communities’ drinking
water, where ClO4
– was detected, had a
median value of 12 µg/L with a range from 5
to 87 µg/L, most of the testing results were
below the detection limit. These concentra-
tions, along with the results of the studies by
Crooks and Wayne (1960) and Greer et al.
(2002), argue against adverse health effects
among California newborns.
Conclusions
In the current study of potential ClO4
– expo-
sure in drinking water and PCH and high
TSH concentrations, we found that PCH
rates in California communities where ClO4
–
concentrations in drinking water average > 5
µg/L were equal to or lower than those in
communities with average ClO4
– concentra-
tions ≤ 5 µg/L. We also found no statistically
or biologically relevant differences between
newborns in these communities with respect
to TSH concentrations. These findings are
consistent with the medical literature, which
reports that most cases of PCH result from
developmental defects of the thyroid. In addi-
tion, most epidemiologic studies to date have
not associated PCH or newborn TSH levels
with exposures to ClO4
– in drinking water.
Recently, the National Academies’ National
Research Council Committee to Assess the
Health Implications of Perchlorate Ingestion
(2005) reviewed the available data from ani-
mal, human, and epidemiologic studies, with
greater emphasis placed on controlled human
studies such as Greer et al. (2002). The com-
mittee concluded that the data across animal,
human volunteer, and epidemiologic studies
were not consistent with a causal association
between exposure to ClO4
– in the drinking
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Appendix 1. Summary of data editing, cleaning, and imputationa applied to
California newborn screening data, 1998.
Newborns from communities with Newborns from
average ClO4
– concentrations communities
> 5 µg/L ≤ 5 µg/L tested for ClO4
–
Newborn Cases Newborn Cases Newborn Cases
Initial data 50,811 15 295,030 127 345,841 142
Imputed or corrected n (%) nn (%) nn (%) n
Collection age imputedb 317 (0.6) 0 3,044 (1.0) 1 3,361 (1.0) 1
Date of birth corrected 40 (0.1) 0 369 (0.1) 0 409 (0.1) 0
Ethnic status assigned to  592 (1.2) 0 2,809 (1.0) 3 3,401 (1.0) 3
Unknownc
Deleted
Multiple records 72 (0.1) 0 356 (0.1) 0 428 (0.1) 0
Birth weightd 383 (0.8) 0 2,450 (0.8) 1 2,833 (0.8) 1
Sex 35 (0.1) 0 316 (0.1) 0 351 (0.1) 0
Out-of-state mother 0 (—) 0 0 (—) 0 0 (—) 0
Other hypothyroidisme 1 (< 0.1) 0 6 (< 0.1) 0 7 (< 0.1) 0
TSH, TSH determination 0 (—) 0 1 (< 0.1) 0 1 (< 0.1) 0
Total records deleted 485 (1.0) 0 3,099 (1.1) 1 3,584 (1.0) 1
Total 50,326 15 291,931 126 342,257 141
aSome records may have invalid or missing information for more than one variable.
bTotal of 5,144 newborns with missing collection age were recovered; 1,951 were
imputed by drawing randomly from a normal distribution. cMissing ethnic status
assigned to Unknown category. dTotal of 4,685 newborns with missing birth weights, 56
with weights < 250 g and 72 with weights > 7,500 g. eInformation on other forms of
hypothyroidism is not routinely reported because the California DHS considers these
data unreliable and not appropriate for analytical purposes.
Appendix 2. Counties with water systems tested for ClO4
–, California, 1998.
No. of communities
with ClO4
– concentration
County ≤ 5 µg/L > 5 µg/L Communities > 5 µg/L
Alameda 4 0
Butte 1 0
Contra Costa 1 0
Inyo 3 0
Kern 5 0
Los Angeles 130 12 Azusa, Baldwin Park, Claremont,   
Covina,Glendora, Hacienda Heights,    
Industry,Irwindale, La Mirada, 
La Puente, La Verne, Newhall
Monterey 1 0
Orange 32 1 La Habra
Riverside 21 1 Riverside
Sacramento 2 3 Gold River, Rancho Cordova,
Sacramento
San Bernardino 14 7 Bloomington, Chino, Colton, Fontana,  
Redlands, Rialto, San Bernardino
San Diego 28 0
San Francisco 1 0
San Mateo 16 0
Santa Barbara 2 0
Santa Clara 16 0
Solano 1 0
Sutter 1 0
Ventura 7 0
Yuba 1 0
Total 287 24Buffler et al.
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water and either congenital hypothyroidism
or thyroid function in normal full-term new-
borns (National Research Council 2005).
Our ﬁndings in this epidemiologic study were
consistent with that conclusion. Despite the
limitations of using aggregate-level exposure
data and the relatively small number of cases
of PCH and high TSH levels even in this full
statewide analysis, these results suggest that
exposure to ClO4
– in drinking water supplies
in California at the levels reported does not
appear to be associated with either PCH or
high TSH levels.
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